PT-141 vs Kisspeptin-10
PT-141 is FDA-approved and rated 4/5 for evidence; Kisspeptin-10 is not FDA-approved and rated 3/5. PT-141 has more human evidence behind it. Kisspeptin-10 is banned in sport by WADA; PT-141 is not. Both are used for sexual health goals.
| Compare | PT-141Works through the brain, not blood flow — and it's FDA-approved for women. | Kisspeptin-10The master switch for reproductive hormones — studied in real human trials. |
|---|---|---|
| Category | Sexual Health | Sexual Health |
| Evidence | 4/5Phase 3 RCTs in women (RECONNECT) led to FDA approval; men's data is smaller. | 3/5Many small human physiology studies and early-phase clinical trials (IVF egg maturation, low sexual desire). No large Phase 3 trials and no approval. |
| FDA status | FDA-approved (Vyleesi, 2019) for premenopausal women with HSDD | Not FDA-approved |
| WADA (sport) | Not prohibited | Banned |
| Also known as | Bremelanotide, Vyleesi | Kisspeptin, KP-10, Metastin 45-54 |
| How it works | Melanocortin-4 receptor agonist in the hypothalamus; acts on desire pathways rather than vascular function. | Activates the KISS1 receptor on GnRH neurons in the hypothalamus, triggering GnRH release. That leads the pituitary to release LH and FSH, which drive testosterone and estrogen production. Brain-imaging studies also suggest it enhances processing of sexual and romantic cues. |
| Half-life | About 2–3 hours | Very short — a few minutes in blood (kisspeptin-10) |
| Commonly reported doses |
|
|
| Route | Subcutaneous (abdomen/thigh) | Subcutaneous |
| Good once mixed | ~28 days in the fridge | ~28 days in the fridge |
| Top side effects |
|
|
| Lowest price per mg | $1.80 (10 mg vial, 40% off) | $3.00 (10 mg vial, 40% off) |
| Latest lab purity | 99.91% (lot PT0002) | 99.24% (lot KSI0001) |
Want a third? Add another peptide. Doses are commonly reported ranges, not recommendations.

